LMR Partners’s Iovance Biotherapeutics IOVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $70.9K | Hold |
41,211
| – | – | ﹤0.01% | 670 |
|
|
2025
Q1 | $137K | Hold |
41,211
| – | – | ﹤0.01% | 672 |
|
|
2024
Q4 | $305K | Hold |
41,211
| – | – | ﹤0.01% | 524 |
|
|
2024
Q3 | $387K | Sell |
41,211
-20,000
| -33% | -$188K | ﹤0.01% | 424 |
|
|
2024
Q2 | $491K | Sell |
61,211
-60,400
| -50% | -$484K | ﹤0.01% | 399 |
|
|
2024
Q1 | $1.8M | Buy |
121,611
+80,400
| +195% | +$1.19M | 0.02% | 239 |
|
|
2023
Q4 | $335K | Hold |
41,211
| – | – | ﹤0.01% | 384 |
|
|
2023
Q3 | $188K | Hold |
41,211
| – | – | ﹤0.01% | 447 |
|
|
2023
Q2 | $290K | Hold |
41,211
| – | – | ﹤0.01% | 440 |
|
|
2023
Q1 | $252K | Sell |
41,211
-10,000
| -20% | -$61.1K | ﹤0.01% | 813 |
|
|
2022
Q4 | $327K | Hold |
51,211
| – | – | 0.01% | 931 |
|
|
2022
Q3 | $491K | Hold |
51,211
| – | – | 0.01% | 874 |
|
|
2022
Q2 | $565K | Hold |
51,211
| – | – | 0.01% | 881 |
|
|
2022
Q1 | $853K | Sell |
51,211
-10,000
| -16% | -$167K | 0.01% | 862 |
|
|
2021
Q4 | $1.17M | Hold |
61,211
| – | – | 0.01% | 646 |
|
|
2021
Q3 | $1.51M | Buy |
61,211
+39,265
| +179% | +$968K | 0.02% | 518 |
|
|
2021
Q2 | $571K | Buy |
+21,946
| New | +$571K | 0.01% | 645 |
|
|
2020
Q4 | – | Sell |
-49,504
| Closed | -$1.63M | – | 550 |
|
|
2020
Q3 | $1.63M | Sell |
49,504
-8,736
| -15% | -$288K | 0.03% | 171 |
|
|
2020
Q2 | $1.6M | Buy |
+58,240
| New | +$1.6M | 0.04% | 292 |
|